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ABSTRACT
The goal of this research project was to study the natural variability of human influenza A and B viruses based on the analysis 
of the population structure of influenza viruses, circulating in Russia in 2006-2013, in order to determine the direction of their 
genetic and antigenic drift by comparison to the WHO reference strains. Our results proved that during that period significant 
changes occurred in the genetic structure of influenza viruses, their phylogenetic affiliation, as well as their sensitivity to antiviral 
drugs. According to the surveillance data, the percentage of influenza A(H1N1) viruses among patients with influenza-like illness 
or acute respiratory infection gradually decreased from 42% of the total number of influenza viruses in 2006-2007 to 19% in 2008-
2009. Influenza A(H1N1) viruses are characterized by «silent» variability that manifests in the gradual accumulation of amino acid 
substitutions in the minor undetectable group of viruses. 
The share of influenza A(H3N2) viruses varied from 10% in the 1st post pandemic year to approx. 60% in 2008-2009 and 2011-
2012 epidemic seasons. All of the influenza A strains isolated during the last years of the period, covered in this study, were found 
to be susceptible to neuraminidase inhibitors and resistant to adamantane antivirals.
Influenza B viruses of both Yamagata and Victoria lineages circulated in Russia in the period from 2006 to 2013. The vast 
majority of these influenza B viruses belonged to the Victoria lineage. Phylogenetic and antigenic analyses of influenza B viruses 
have demonstrated a gradual drift of Russian isolates from the reference strains. No changes leading to resistance to oseltamivir 
or zanamivir were found in influenza B strains isolated until 2013.
INTRODUCTION
Influenza and other acute respiratory infections in Russia 
are still far more common and uncontrolled infections. 
According to The Russian Ministry of Health data, more 
than 80% of all infectious diseases in Russia fall to the 
share of influenza and acute respiratory infections, and 
their economic impact is approx. 85% of the total damage 
caused by infectious diseases. Influenza is an example 
of a disease caused by a virus, a constant evolution of 
which leads to annual epidemics. The essential feature 
of influenza viruses’ evolution is associated with the 
accumulation of mutations leading to antigenic drift and 
appearance of new viral strains resulting in heterogeneity 
of viral populations and formation of different genetic 
lines [1]. The relationship between the dynamic prevalence 
of certain phylogenetic lines of influenza viruses and 
their geographical distribution was registered during the 
past decade. Dramatic changes in the genetic structure 
of influenza A virus can evolve by the reassortment of 
the genomic segments of different subtypes circulating 
in humans and animals [2]. The emergence of a new 
pandemic strain of influenza virus A(H1N1pdm2009) 
in 2009 confirmed the potential of the evolutionary 
variability and unpredictable shift of the influenza virus. 
Continuous etiological surveillance of influenza 
on the national and global level carried out in the 
framework of cooperation between National Centers for 
Influenza and Collaborating Centers for Influenza of the 
World Health Organization (WHO) is of great importance 
for the investigation of virus evolution and forecast 
of the next epidemic season. In this paper, we describe 
the molecular evolution of influenza A and B viruses 
circulated in Russia in 2006-2013. 
The goal of this research project was to study the 
natural variability of human influenza A and B viruses, 
based on the analysis of the population structure of 
influenza viruses circulating in Russia in order to 
determine the direction of their genetic and antigenic 
drift by comparison to the WHO reference strains. 
MATERIALS AND METHODS
Viruses
In this paper we present the results of analysis of more 
than 420 strains of influenza A and B viruses isolated from 
clinical specimens (nasopharyngeal swabs and throat, 
bronchial-alveolar lavage, cell material) during seven 
epidemic seasons (2006-2013) in the Research Institute 
of Influenza as well as received from 33 Regional Basic 
Laboratories according to “Rospotrebnadzor” program 
from the cities Astrakhan, Belgorod, Cheboksary, Volgograd, 
Vologda, Vladivostok, Yekaterinburg, Irkutsk, Kaliningrad, 
Krasnoyarsk, Kursk, Lipetsk, Moscow, Murmansk, 
Nizhny Novgorod, Novosibirsk, Orenburg, Omsk, 
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Petropavlovsk-Kamchatsky, Rostov-on-Don, Ryazan, 
Samara, St. Petersburg, Smolensk, Stavropol, Tomsk, Tver, 
Tula, Ulan-Ude, Khabarovsk, Chita, Chelyabinsk, and 
Yakutsk. Reference strains were obtained from the Centers 
for Disease Control and Prevention (CDC Atlanta, GA, USA).
Virus isolation was performed in MDCK cell culture 
and 10-day-old chicken embryos (CE) incubated for 
72 hours at 34ºC according to the approved method [3]. 
Hemagglutination Inhibition (HI) test
HI test was performed according to the standard method 
recommended by the WHO, with 0.75% suspension of 
human red blood cells group 0 for all epidemic viruses. In 
the case of pandemic influenza A(H1N1)pdm09 isolates 
1% suspension of chicken erythrocytes was used [4].
Antisera
Influenza reference antisera obtained from the WHO 
Reference Center (CDC, Atlanta, USA) and rat strain 
specific antisera to Russian representative isolates and 
WHO reference strains were prepared in the Research 
Institute of Influenza. 
Sequencing
RNA extraction was made using commercial RNeasy 
Mini Kit (Qiagen, Germany). Reverse transcription of the 
RNA was performed by Reverta-L kit (InterLabService, 
Russia). The amplification of cDNA was performed by the 
standard method using the original primers. Sequencing 
of influenza virus A genome fragments (genes HA, NA, 
M, NS, and NP) was carried out on ABI PRISM 3100-Avant 
Genetic Analyzer (Applied Biosystems, USA) with 
“BigDye Terminator Cycle Sequencing Kit v3.1”.
Phylogenetic analysis
The processing and analysis of sequences was performed 
using the software Vector NTI v10.1.1 (Invitrogen) and 
MEGA 5 (PSU, USA). The method of maximum likelihood 
(ML) was used to build phylogenetic trees. The choice of 
evolutionary models was implemented by Akaike criterion 
(AIC) value using ModelTest v3.7 program [5]. Algorithm 
SLAC was used to search for sites of positive selection [6].
RESULTS AND DISCUSSION
The results of the analysis of the antigenic properties and 
genetic structure of representative samples of influenza 
A and B strains circulated in the Russian Federation in 
2006-2012 epidemic seasons are presented below.
Influenza viruses A(H1N1) 
Influenza A(H1N1) viruses in Russia during this period, 
as in other countries, occurred more rarely than influenza 
A(H3N2) and B viruses. The etiological structure of influenza 
viruses during 7 epidemic seasons (2006-2013) is shown in 
Table 1. The percentage of detection of these viruses to 
the total number of influenza viruses among patients with 
influenza-like illness or acute respiratory infection (ILI/
ARI) gradually decreased from 42% in 2006-2007 to 19% 
in 2008-2009. Significant epidemic events caused by this 
pathogen were recorded infrequently. However, the gradual 
accumulation of point mutations in HA and NA genes led to 
changes in the antigenic profile of the surface proteins and 
the emergence of a new drift variant of A(H1N1) virus. 
All A(H1N1) strains isolated in 2006-2007 could be 
divided into two antigenically separate groups: a group 
that differed from both the old (A/New Caledonia/20/1999) 
and the new (A/Solomon Islands/3/2006) vaccine 
strains and the group which was very close to the new 
reference strain A/Solomon Islands/3/2006. However, 
a population of the latter A(H1N1) viruses was quite 
small in number and, therefore, a vaccine containing this 
component, would not be fully protective against the 
disease. Phylogenetic analysis showed that 2006-2007 
influenza A viruses of H1N1 subtype were also related to 
two genetic groups - clades 1 and 2. Strains belonging to 
clade 1 were similar to A/New Caledonia/20/1999 vaccine 
strain (Fig. 1). Viruses containing specific substitutions 
T82K, Y94H, R145K, R208K, R225K in the hemagglutinin 
(HA) and V234M, D382N in neuraminidase (NA) formed 
genetically heterogeneous group of clade 2 viruses. The 
Table 1. Etiological structure of influenza viruses during 7 epidemic seasons (2006-2013) according to ILI/ARI morbidity data (Russian 
National Influenza Center).  
Epidemic period Viruses of each subtype/type as a percentage to the total number of influenza viruses  
among Russian ILI/ARI patients
A(H1N1) A(H1N1)pdm09 A(H3N2) B*
2006-2007 42 0 32 26
2007-2008 38 0 29 33 (94% Vic)
2008-2009 19 0 63 18 (98% Yam)
2009-2010 0 99 0 1 (100% Vic)
2010-2011 0 65 10 25 (100% Vic)
2011-2012** 0 1 63 36 (70% Vic)
2012-2013 0 41 39 20 (87% Yam)
*- % of prevalent lineage (Yamagata (Yam) or Victoria (Vic)) is indicated in brackets.
**- The season of very low influenza activity.
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Fig. 1. HA phylogenetic tree of influenza A(H1N1) viruses 
The tree was constructed using maximum likelihood method, CTR+G+I model, bootstrap 1000 replications. Viruses sequenced in the 
Research Institute of Influenza are marked in bold. ¿ – vaccine viruses.
circulation of influenza A clade 2A viruses similar to the 
A/Solomon Islands/3/2006 vaccine strain was practically 
not registered during this period in Russia. Viruses that 
circulated during this period formed a separate group 
and were the predecessors of clade 2C viruses, which 
appeared in 2007 with the substitutions S36N, A189T 
in HA, and S82K, M188I in NA. A minor incidence of 
A(H1N1) viruses similar to A/Brisbane/59/07 (clade 2B) 
has been observed in Russia since 2007.
Influenza A(H1N1) viruses also actively circulated 
throughout Russia during the next epidemic season 
(2007-2008) and were isolated in 13 cities. Antigenic 
analysis of isolates showed that all of them, regardless of 
the place of isolation, finally lost antigenic relationship 
with the old reference strain A/New Caledonia/20/1999; 
they practically did not react with serum antibodies 
raised against this reference strain.
Those isolates can be divided into two groups by 
comparison of their antigenic characteristics with 
A/Solomon Islands/3/2006 reference virus. The first 
group interacted with the antiserum within 2-fold of the 
homologous titer. This group contained only 17.2% of the 
isolated A(H1N1) viruses. The second group reacted with 
the serum raised against A/Solomon Islands/3/2006 within 
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a fourfold to eightfold reduction of homologous titer. At 
the same time, the epidemic 2008 isolates interacted 
quite well with antiserum against A/Brisbane/59/2007 
(within to 1-2-fold of homologous titer).
Thus, the majority of influenza A(H1N1) viruses 
that circulated in Russia in 2007-2008 differed from 
the reference strains A/New Caledonia/20/1999 and A/
Solomon Islands/3/2006 and were closer to the reference 
strain A/Brisbane/59/2007 according to their antigenic 
characteristics. These viruses were continued to be found 
in the 2008-2009 season. Strains of two antigenic types: A/
Brisbane/59/2007-like and antigenically related to A/Hong 
Kong/1870/2008 were circulating during this epidemic 
season in Russia.
A(H1N1) viruses of the 2008-2009 season made up 
18.7% of all isolated influenza viruses in this season. 
Most viruses of this subtype have been isolated in Siberia 
and the Far East. Viruses similar to A/Brisbane/59/2007 
vaccine strain, which belongs to clade 2B, caused this 
epidemic flu season in Russia. Prevalence of A(H1N1) 
viruses of clade 2B was typical not only for Russia but for 
the world as a whole. Among the investigated strains of 
viruses isolated in the Far East and Siberia, we also found 
representatives of clade 2C (A/Vladivostok/83/2008, A/
Khabarovsk/3/2009, A/Novosibirsk/9/2009, etc.), which 
intensively circulated in the Asia-Pacific region [7].
We have shown that HA of Russian clade 2B 
representatives is characterized by substitutions D35N, 
R188K, K145R, and clade 2C representatives – by 
substitutions S36N, K82R, R145K, R188M, A189T and 
T193K. The differences in the antigenic structure of 
the representatives of these two clades could be caused 
by mutations in the coding regions for antigenic site 
Ca2 (K145R), Cb (K82R) and Sb (T193K). 2008-2009 
strains of clade 2B differed from the previously isolated 
representatives of this clade by the substitution A189T.
The last A(H1N1) viruses related to the new evolutionary 
branches have lost any relationship with the old reference 
strains and interacted poorly with appropriate antisera. 
Feedbacks were also absent, i.e. serum antibodies to new 
antigenic variants of the virus did not neutralize strains 
of previous years. These data suggest significant genetic 
differences between the viruses of these clusters. Influenza 
A(H1N1) viruses are characterized by «silent» variability 
that manifests in the gradual accumulation of amino acid 
substitutions in the minor undetectable group of viruses. 
Such variability is often divergent [8, 9]. The emergence 
and spread of a few antigenically separate clusters of 
influenza A(H1N1) viruses in 2006-2007 support this 
hypothesis. The subsequent epidemic events showed that 
the strains similar to A/St.Petersburg/96/2007 (antigenic 
variant of A/Brisbane/59/2007 strain) had the largest 
epidemic potency and selective advantage.  
In the HA sequences of influenza A(H1N1) clade 2B 
representatives, two codons with selective advantages 
(codons 186 and 227) have been identified (probability 
more than 95%). According to X-ray analysis, residue 186 
is the part of the receptor-binding site of HA (helix 190), 
which is presumably involved in hydrogen bonding with 
sialo-pentasaccharide [10, 11].
Substitutions G249K and T287I were detected in NA 
of clade 2B strains (data not shown), and substitutions 
M188I, I267M, L367I in 2C clade strains. Substitutions 
M188I, G249K, T287I and L367I are located in the so-
called phylogenetically relevant areas D, F, H and L, 
respectively. L region of NA of N1 subtype is known to 
form antigenic site [12]. Most of NA sequences of N1 
clade 2B strains have mutation H275Y that leads to 
oseltamivir resistance, although these strains do not 
form a separate phylogenetic group within clade 2B. 
Among the representatives of clade 2C oseltamivir-
resistant strains have not been identified.
No strains with resistance determining mutation 
S31N to rimantadine in the M2 protein were identified 
among clade 2B strains in contrast to rimantadine 
resistant strains of clade 2C.
All studied representatives of clade 2C contained the 
substitution S207N in the M1 protein typical for influenza 
A(H5N1) strains belonging to Qinghai group (Qinghai-like, 
e.g. A/bar-headed goose/Qinghai/12/2005). However, the 
role of this substitution in M1 protein of human influenza 
A(H1N1) viruses remains unclear. It is known though, that 
mutations in the C-terminal domain of M1 protein may 
occur during virus adaptation to mice and are associated 
with increased pathogenicity of influenza A viruses [13].
Influenza viruses A(H1N1)pdm09 
A(H1N1)pdm09 epidemic in Russia began in the middle 
of September 2009 and had a monoetiologic character. 
Influenza A(H1N1)pdm09 viruses also dominated in 
Russia during the 2010-2011 epidemic season (Table 1).
All isolated viruses were homogeneous in their 
antigenic properties and reacted with A(H1N1)pdm09 
diagnostic antiserum obtained from CDC as well as with 
antiserum raised against A/California/07/2009 strain 
within 1-4-fold of the homologous titer. 
Population of A(H1N1)pdm09 strains was 
genetically homogeneous and evolutionarily related 
to five phylogenetic groups [14] belonging to the world 
dominant clade 7 with characteristic S203T substitution 
in HA (Fig. 2). All viruses other than those of clade 1 
contained P83S substitution in HA. Interestingly, these 
strains contained valine residue at position 321, which 
is located near the cleavage site of the HA molecule. 
However, in a significant number of Russian isolates in 
2009 we observed a reversion V321I in HA. A number of 
2009-2011 strains contained substitutions in antigenic 
site Ca, Sb and Sa. Strains isolated in 2010-2011 were 
characterized by mutational changes that were the result 
of virus adaptation to the immunized human population. 
We did not find any significant changes of the genetic 
structure of HA, NA, M, NS and NP genes of the analyzed 
strains [15]. None of these strains had oseltamivir 
resistance mutation (H275Y), but all strains carried the 
mutation S31N in M2 leading to rimantadine resistance. 
Most strains (82%) isolated from the autopsy materials 
of patients with laboratory confirmed flu contained 
substitution D222G in the HA receptor-binding site.
Our findings confirm that all A(H1N1)pdm09 virus 
strains of the 2012-2013 epidemic season belonged 
to clade 6 (А/Saint Petersburg/27/2011-like). Analyzed 
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strains were genetically homogenous contrary to the 
situation of 2010-2011 season when influenza A(H1N1)
pdm09 strains belonged to 5 phylogenetic groups. 
Sequencing of HA1 subunit of 5 viruses, isolated from 
autopsy materials, showed amino acid substitutions in 
four of them: D222G in 2 viruses and Q223R in 2 viruses. 
No specific antigenic properties were found in influenza 
A(H1N1)pdm09 viruses isolated from autopsy samples 
when compared with viruses isolated from patients who 
recovered from this infection. 
The analysis of sites - subjects to positive selection - 
identified three codons in the HA sequence of influenza 
A(H1N1)pdm09 virus: 239, 289 and 391. Mutation at 
position 222 of HA1 (codon 239) leads to the extension of 
receptor specificity. Amino acid at position 47 of HA2 (codon 
391) is located in the epitope CR6261, which is recognized 
by the CR6261 antibody. The neutralizing effect of this 
antibody is associated with HA fusion [16]. According to the 
molecular modeling data, the mutation E391K was shown 
to strengthen the interaction between the HA monomers 
and weaken intrasubunit interactions [17].
Influenza viruses A(H3N2) 
Influenza A(H3N2) viruses circulated on the territory of 
Russian Federation during the entire observed period 
except the 2009-2010 season when new H1N1 pandemic 
Fig. 2. HA phylogenetic tree of influenza A(H1N1)pdm09 viruses 
The tree was constructed using maximum likelihood method, TN93+G model, bootstrap 1000 replications. Viruses sequenced in the Research 
Institute of Influenza are marked in bold. ¿ – vaccine viruses. Genetic groups of reference viruses are shown in italic and underlined.
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happened. The frequency of isolation of this (A(H3N2)) 
virus varied from 10% in 2010-2011 to about 60% in 
2008-2009 and 2011-2012 epidemic seasons (Table 1).
Influenza A(H3N2) viruses of 2006-2007 epidemic 
season were isolated in 13 Regional Basic Laboratories. 
A detailed study of the antigenic structure of viruses 
isolated during this epidemic showed no significant 
antigenic drift when compared with reference strains and 
viruses of previous years. On the other hand, we did not 
observe any new variants of influenza A(H3N2) virus. It 
should be noted that a gradual extinction of similarity 
between modern isolates and viruses of 2004-2005 
epidemic seasons was observed. 2006-2007 strains reacted 
with antiserum against A/California/07/2004 reference 
strain with HI titers 4-fold to 16-fold reduced compared 
with the titer of the homologous virus. The analysis of 
the interactions of 2006-2007 isolates with antiserum 
to A/Wisconsin/67/2005 reference strain showed that 
this vaccine component was relevant and the produced 
antibodies had broad-spectrum activity: they neutralized 
the strains isolated in previous years with the HI titers –
twofold to fourfold of the homologous titer. Furthermore, 
isolated viruses could not be divided into distinctive 
groups according to their reactivity with antiserum neither 
to the reference strains nor to the epidemic strains. Тhe 
occurrence of viruses demonstrating good neutralizing 
activity with antiserum against A/Wisconsin/67/2005 
reference strain is also noteworthy.
Isolated influenza A(H3N2) viruses of 2006-2007 
epidemic season differed significantly by their genetic 
characteristics (Fig. 3). However, in this period, we 
observed A/Wisconsin/67/2005-like viruses with a 
number of substitutions in HA (T128A, R142G, K173E). 
Substitution T128A resulted in the loss of potential 
glycosylation site. Substitutions K173E and R142G, which 
were found in the strains, isolated in previous years (e.g. 
A/Johannesburg/33/1999), resulted in the change of the 
glycoprotein charge. A number of viruses in this group had 
substitution L157S in the antigenic site B1, substitution 
N145K in A site and substitution D188E in B2 site. The 
substitutions S193F (antigenic site B2), N216S (antigenic 
site D) and V112I, K173E were also noted in circulating 
viruses. On the other hand, the second group consisted 
of A/Brisbane/10/2007-like strains, recommended by the 
WHO for vaccine production in 2008, which have new 
substitutions G50E and K140I.
Influenza A(H3N2) viruses were registered in 15 cities 
of Russia during the 2007-2008 epidemic season, but 
their share was small in comparison to A(H1N1) and B 
viruses, accounting for only 15% of all isolates. In the 
2008-2009 epidemic season, influenza A(H3N2) viruses 
constituted the majority of the isolated strains (58.7%) 
and were observed in 19 cities of different regions of 
Russia. All of the studied strains were related to A/
Wisconsin/67/2005 reference strain and epidemic isolates 
of the previous season. Sera to A/Wisconsin/67/2005 and 
A/Saint Peterburg/71/2007 strains neutralized Russian 
isolates of 2009 with 2-8-fold reduction compared to the 
homologous titer.
Summarizing the results of the antigenic analysis of 
2006-2009 influenza A(H3N2) viruses, we can conclude 
that these isolates were mostly homogeneous with small 
proportions of drift variants. This can be attributed to 
the lack of or insignificant changes in HA and NA surface 
proteins of the influenza viruses. 
Influenza A(H3N2) viruses of 2007-2009 
epidemic seasons were genetically related to the A/
Brisbane/10/2007 vaccine strain (Fig. 3). These strains 
were characterized by HA amino acid substitutions G50E 
(antigenic site C) and K140I (antigenic site A) as well as 
NA substitutions N93D, H150R and Y194I while M1 and 
M2 proteins did not carry any substitutions. Most of the 
analyzed 2007 strains carried the rimantadine resistance 
mutation (S31N) in the M2 protein. Within this genetic 
clade we found a small separate cluster of viruses, 
containing specific HA and NA mutations, consisting of 
a number of Moscow isolates (e.g. A/Moscow/118/2008). 
The HA sequences were characterized by the substitution 
K92R, while NA sequences were found to contain two 
synonymous mutations: 351 A>G (A to G) (in T117 codon) 
and 408 G>A (G to A) (in Q136 codon).  
Almost all M1 sequences of 2008 strains contained an 
amino acid residue substitution K174R. We did not find 
any strains related to the new phylogenetic lineage of A/
Perth/16/2009-like viruses among the analyzed strains. 
Thus, influenza A(H3N2) viruses isolated during 2008-
2009 were proved to be the evolutionary continuation of 
strains of the 2007-2008 epidemic season.
The substitution D147N has been found in the 
glycosylation site of NA sequences of the majority of 
A(H3N2) 2008 influenza viruses and all 2009 viruses. It is 
known that the glycosylation at position 130 of N1 (which 
corresponds to position 146 in N2) of A/WSN/33 (H1N1) 
impairs the neuraminidase interaction with plasminogen 
and reduces the virus pathogenicity [18].
The vast majority of influenza A(H3N2) strains 
isolated in 2008 carried K174R mutation in M1 protein 
C-terminal domain, which facilitates the formation of its 
α-helix conformation [19]. The M2 protein of all studied 
2008 strains contains a mutation (S31N) leading to 
rimantadine resistance.
Influenza A(H3N2) viruses did not circulate during 
the 2009-2010 epidemic season in Russia and had no 
epidemiological significance during 2010-2011: sporadic 
detections of influenza viruses of this subtype were 
reported in the European part of Russia, and showed 
a weak activity in Siberia and the Far East. We showed 
that all viruses isolated in the east of Russia (2006-
2013) belonged to A/Victoria/210/2009 genetic group 
(R261Q) of A/Perth/16/2009 clade (E62K, N144K). The 
HA of these viruses contains a number of changes in the 
antigenic site E2. Viruses isolated in the European part 
of Russia belonged to the A/Perth/10/2010 genetic group 
of A/Victoria/208/2009 clade and had substitutions in 
the antigenic site C. All of the studied A(H3N2) strains 
isolated in 2010-2011 contain a mutation (S31N) in the 
M gene determining resistance to rimantadine.
All of the studied influenza A(H3N2) viruses of 
the 2011-2012 epidemic season are related to the 
A/Stockholm/18/2011 genetic group (V223I) of A/
Victoria/208/2009 clade and contain HA N312S amino 
acid substitution. These strains could be divided into 
Surveillance of influenza A and B viruses 
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Fig. 3. HA phylogenetic tree of influenza A(H3N2) viruses 
The tree was constructed using maximum likelihood method, TN93+G model, bootstrap 1000 replications. Viruses sequenced in the 
Research Institute of Influenza are marked in bold. ¿ and ¯ – vaccine viruses.
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two subgroups. The first subgroup includes viruses with 
substitutions N145S in the antigenic site A and A198S 
in antigenic site B2 (e.g. A/Saint Petersburg/60/2012, A/
Astrakhan/65/2011); second subgroup includes viruses 
with substitutions S145N, D487N, Q33R, S45N related to 
the emergence of the potential glycosylation site. Viruses 
with substitutions T48I, N278K in antigenic site C and 
T128N, A198P in antigenic site B2 form subgroups 3B 
and 3C respectively (e.g. A/Kaliningrad/15/2012, A/Saint 
Petersburg/50/2012).
Analysis of NA sequences of Russian A(H3N2) strains 
of 2006-2012 did not reveal mutation E119V that leads to 
oseltamivir resistance.
According to the results of the detailed antigenic 
analysis, the majority of influenza A(H3N2) strains isolated 
in 2011-2012 were related to the A/Perth/16/2009 reference 
strain. These viruses interacted with the appropriate 
antiserum fourfold reduced compared to the homologous 
titer. However, we found some strains with the HI titer 
eightfold reduced in comparison with the homologous 
titer. Further analysis showed that all of the studied 
Russian isolates were antigenically close to the viruses 
of A/Victoria/208/2009 subgroup. These isolates reacted 
with antibodies against A/Victoria/208/2009 strain up to 
fourfold decrease of the homologous titer. Nevertheless, 
we found in this subgroup some strains, which reacted only 
with eightfold reduction of the homologous titer (e.g. A/
Astrakhan/7/2012). All isolates reacted with antiserum to 
Russian representative strain A/Saint Petersburg/10/2012 
1-4 fold less compared to the homologous titer. The 
latter strains differed from the reference strains in their 
interaction with antisera to viruses isolated in 2009 (A/
Perth/16/2009, A/Victoria/208/2009, A/Victoria/210/2009). 
Although, like other strains of the 2012-2013 season, they 
reacted poorly with antisera to the new reference viruses 
A/Victoria/361/2011 selected by the WHO experts to be 
included in the vaccine for the 2012-2013 season [20]. This 
proves that influenza A(H3N2) viruses had a unique path 
of evolution in Russia. 
The phylogenetic analysis of the HA gene of influenza 
A(H3N2) viruses isolated in the 2011-2012 epidemic 
period showed that the vast majority of strains belonged 
to A/Victoria/208/2009 clade. They were related to the 
A/Victoria/361/2011-like group and could be divided 
into two subgroups: the first subgroup includes 
viruses with substitutions N145S (antigenic site A) 
and D487N (e.g. strains A/Saint  Petersburg/01/2012, A/
Petrozavodsk/01/2012); the second subgroup includes 
viruses with substitutions Q33R, S45N (emergence of a 
new potential glycosylation site), T48I, N278K (antigenic 
site C) (e.g. A/Omsk/01/2012 and A/Novosibirsk/08/2012). 
It should be noted that the strains A/Omsk/01/2012, A/
Novosibirsk/08/2012, and A/Novosibirsk/09/2012 have 
the amino acid substitution A198P in the antigenic site 
B2. The other 3 strains, isolated in the same epidemic 
period, were related to the A/Stockholm/18/2011-like 
group (Fig. 3): they have amino acid substitutions V223I 
and N312S unlike A/Victoria/208/2009
None of the strains analyzed in 2012 belonged to the 
A/Perth/10/2010-group A/Victoria/208/2009-clade with 
characteristic substitutions D53N, Y94H, I230V, and E280A.
All of the isolates of the season 2012-2013 interacted 
poorly in HI test with the antiserum raised against 
egg-derived А/Victoria/361/2011 strain, as well as with 
antiserum to the egg-derived reference strains of 2012 
such as А/South Australia/30/2012 and А/Ohio/2/2012. 
At the same time, the majority of 2011-2013 isolates 
revealed high HI titers with antiserum raised against 
cell-grown reference virus А/Victoria/361/2011.
The HA phylogenetic analysis of influenza A(H3N2) 
strains isolated in the 2012-2013 epidemic period showed 
that all of the strains were A/Victoria/361/2011-like 
(subgroup 3C of A/Victoria/208/2009 clade), since their 
structure was defined by amino acid changes S45N, T48I, 
S145N, A198S, V223I and N312S. The majority of these 
strains contained substitution T128A in HA1 presumably 
leading to the loss of glycosylation site at position 126. 
Substitutions in antigenic site A (N121D, S124N, I140M) 
are common for these strains. 
All influenza A strains isolated during the last years 
of the reported period were found to be susceptible to NA 
inhibitors and resistant to adamantane antivirals. None 
of them carried H275Y substitution in NA, and all had 
S31N substitution in M2.
Influenza B viruses
Influenza B viruses of both Yamagata and Victoria 
lineages circulated in Russia in the period from 2006 
to 2013. The vast majority of influenza B viruses 
belonged to the Victoria lineage. The occurrence of B/
Malaysia/2506/04-like strains was observed in Russia 
during 2006-2007 epidemic season. All isolates reacted 
with antiserum raised against this strain onefold to 
fourfold of the homologous titer. However, the emergence 
of viruses belonging to B/Brisbane/60/2008-like strains 
of Victoria lineage was registered in 2008-2009 season. 
Circulation of these viruses continues to the present 
day. Influenza activity of the Yamagata lineage was not 
that intense in the observed period. Viruses of Yamagata 
lineage clearly prevailed over the Victoria one only in 
2007-2008 season: 98% of all isolated influenza B viruses 
were B/Florida/4/2006-like. The next occurrence of 
Yamagata group viruses was registered only in 2011-2012 
season when viruses, related to the new vaccine strain B/
Wisconsin/1/2010 made up 30% of all isolates.
We performed the phylogenetic analysis of HA gene 
fragments of influenza B strains isolated in different 
regions of the Russian Federation in the 2011-2012 
epidemic season (Fig. 4). The analysis of influenza B 
strains isolated in previous seasons showed that all of 
them belonged to the Victoria lineage clade III-ii or B/
Brisbane/60/2008-like strains. Considering that the 
influenza B viruses of the Victoria lineage circulated in 
Russia during 3 epidemic seasons, we could expect the 
emergence of influenza B of the Yamagata line in Russia 
in the epidemic of 2011-2012.
As expected, influenza B of both the Victoria and 
Yamagata lineages were found during 2012-2013 epidemic 
season in Russia. The HA phylogenetic analysis of 4 strains, 
belonging to Yamagata lineage, isolated in 2012 showed 
that they all are related to the B/Bangladesh/3333/2007-like 
group with substitutions N165Y and S150I in the antigenic 
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sites BB2 and BA, respectively (Fig. 5). Furthermore, 
the strains isolated in Russia in 2012 (for example, B/
Novosibirsk/01/2012) have HA substitutions K298E, 
E312R, and N116K (antigenic site BC). The 11 analyzed 
strains of 2012 belonged to the B/Brisbane/60/2008-
like strains of the Victoria lineage and have a number of 
amino acid substitutions: N75K (antigenic site BE), N165K 
(antigenic site BB2) and S172P (Fig. 4). In addition, all the 
Russian isolates had the following substitutions in the 
HA: L58P (antigenic site BE) and V146I (antigenic site BA) 
in the Victoria lineage strains and T181K (antigenic site 
BD) in the Yamagata lineage strains. 
In 2012-2013 season, the simultaneous circulation of 
influenza B strains of Yamagata and Victoria lineages was 
also observed with the prevalence of Yamagata lineage 
(87%) (Table 1). 
2012-2013 Yamagata lineage strains were similar to 
the reference strain В/Wisconsin/01/2010, which was 
included in the vaccine composition for this season 
(2012-2013). These viruses were also similar to the 
Russian isolates of 2012-2013 and to the new reference-
strain В/Massachusetts/2/2012, proposed by the 
WHO to be included into the seasonal vaccine for the 
Northern Hemisphere for the season 2013-2014. At the 
same time, they have some relationship to the earlier 
strain В/Bangladesh/3333/2007. Antigenic cartography 
of influenza viruses B of Yamagata lineage (data not 
shown) has demonstrated a gradual drift of Russian 
Fig. 4. HA phylogenetic tree of influenza B/Victoria viruses 
The tree was constructed using maximum likelihood method, HKY+G model, bootstrap 1000 replications. Viruses sequenced in the 
Research Institute of Influenza are shown in bold. ¿ – vaccine viruses.
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isolates from the reference strains В/Florida/07/2004 
and B/Florida/04/2006 (strains isolated during 2005-
2008) to the strains similar to the reference virus В/
Wisconsin/01/2010 and its Russian analogue В/Saint 
Petersburg/24/2012. At the same time, the reference 
strain В/Bangladesh/3333/2007 has an intermediate 
position on two-dimensional cartogram between the two 
above mentioned groups.
According to the results of antigenic analysis, all of 
the B/Victoria lineage strains were similar to the vaccine 
reference strain В/Brisbane/60/08 and reacted with the 
antiserum to that strain up to 4- fold of the homological 
titer. All isolates of the 2012-2013 season also reacted well 
in the HI test with antisera to the Russian strains isolated 
in 2009-2013. Some of them were chosen as “local” 
reference viruses of the Research Institute of Influenza. 
All strains of B/Victoria lineage isolated in 2012-2013 
season fell into clade 1A and have common substitution 
K209T in HA1 subunit unlike B/Victoria strains isolated 
in 2012 that fell into clades 1A and 1B which have N197K 
and T199A substitutions in HA receptor-binding site 
(Fig. 4). No intra-clade reassortant HA-1A/NA-4 was 
identified in this season. B/Yamagata lineage strains of 
clade 2 (B/Brisbane/03/2007-like) contained amino acid 
changes R48K (antigenic site BC), I150S (antigenic site 
BA), Y165N (antigenic site BB2), T181A (antigenic site 
BD). Only two of these strains belonged to clade 3 (B/
Wisconsin/01/2010-like) (Fig. 5).
No changes leading to resistance to oseltamivir or 
zanamivir were found in influenza B strains isolated 
until 2013.
Thus, we studied the antigenic and genetic diversity 
of influenza A and B viruses that circulated in Russia 
in 2006-2013. The analysis of this data proves that in 
this period significant changes occurred in the genetic 
structure of influenza viruses isolated on the territory of 
Russia, as well as in their sensitivity to antiviral drugs and 
phylogenetic affiliation. In addition, since the summer of 
2009, a new pandemic influenza virus A(H1N1)pdm09 
began to spread in Russia.
Fig. 5. HA phylogenetic tree of influenza B/Yamagata viruses 
The tree was constructed using maximum likelihood method, HKY+G model, bootstrap 1000 replications. Viruses sequenced in the 
Research Institute of Influenza are shown in bold. ¿ and ¯ – vaccine viruses.
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The identification of codons under the pressure of positive 
selection in silico in the genes encoding surface proteins 
of influenza viruses might be very informative for the pre-
diction of their antigenic drift and evolutionary variability.
Continuous monitoring of the mutational variability and 
phylogenetic analysis of circulating strains play an impor-
tant role in the selection of vaccine strains for influenza spe-
cific prevention and antiviral drugs. Phylogenetic analysis is 
also a powerful tool for identifying new reassortants that 
could have epidemic or pandemic potential.
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